focus -WSS

focus

author：entertainment 2025-10-03 00:40:13 - browse：443

Doctor sitting at a crowded desk. -- first opinion coverage from STAT — Adobe

SAN FRANCISCO — If you learned anything about nonprofit hospitals on the first day of the J.P. Morgan Healthcare Conference, it’s that they’ve all but abandoned the prospect of making significant profit on patient care. Instead, they’re fully throwing their weight into other ways of making money — things like developing drugs or selling insurance.

Making money outside of patient care — or “revenue diversification,” if you prefer industry jargon — has always made appearances on hospital slides at the annual investor conference in San Francisco. This year, though, hospital executives are projecting a sense of urgency around growing profit in other areas to make up for losing money on their bread and butter: taking care of patients in hospitals.

“It used to be nice to have, but now it’s a must-have, especially for not-for-profit health systems,” Niyum Gandhi, the chief financial officer of Boston’s Mass General Brigham said in an interview with STAT after his presentation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Eliminate the waiting period for sterilization covered by Medicaid

WSS

What don’t we know about an Alzheimer’s drug side effect?

How to pay for weight loss drugs and save Medicare

Organ aging and disease risk measured by new blood test

FDA investigates CAR

UnitedHealth’s Optum accused of antitrust violations in California

Donor acceptance rates hint at racial, gender bias in heart transplants: study

hotspot

focus

entertainment

Anesthesiologist group: stop taking Ozempic before surgery

Donor acceptance rates hint at racial, gender bias in heart transplants: study

What does generative AI mean for health care? We asked experts

States should stop sabotaging methadone treatment reform

Anesthesiologist group: stop taking Ozempic before surgery

Merck drug for rare lung condition set for approval in U.S.

DIEP, the 'gold standard' of breast reconstruction, is under threat

Merck drug for rare lung condition set for approval in U.S.

United colonoscopy coverage change 'may cost lives,' doctors say

J&J to emphasize cancer drugs, stop much of its vaccine research

entertainment

Fetal surgery at risk from Dobbs and new abortion restrictions

J&J to emphasize cancer drugs, stop much of its vaccine research

Why the world’s most expensive drug might be worth the price

30 years of 'Listening to Prozac'

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Scientists boost immune system in aging mice by making it youthful

leisure time

leisure time

focus

focus